Shopping Cart
Remove All
Your shopping cart is currently empty
Livmoniplimab (Synonyms: MHG-8, MHG8, ARGX-115, ARGX115, ABBV-151, ABBV151)
Catalog No. T77067 Copy Product Info
🥰Excellent
Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, which blocks TGFβ1 release mediated by LRRC32, for the treatment of locally advanced or metastatic solid tumours.
Livmoniplimab
Copy Product Info🥰Excellent
Catalog No. T77067
Synonyms MHG-8, MHG8, ARGX-115, ARGX115, ABBV-151, ABBV151
Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, which blocks TGFβ1 release mediated by LRRC32, for the treatment of locally advanced or metastatic solid tumours.
Livmoniplimab
Cas No. 2412004-88-5
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $257 | - | In Stock | |
| 5 mg | $668 | - | In Stock | |
| 10 mg | $1,070 | - | In Stock |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Batch Information
Select Batch
Purity:≥95% (SDS-PAGE); 98.71% (SEC-HPLC)
Appearance:Liquid
Color:Transparent
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Livmoniplimab (ABBV-151; ARGX-115) is a humanised monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, which blocks TGFβ1 release mediated by LRRC32, for the treatment of locally advanced or metastatic solid tumours. |
| In vivo | Method: Seven-week-old female B-hGARP mice were subcutaneously inoculated with MC38 mouse colon cancer cells to establish tumor models. Livmoniplimab was administered at a dose of 250 μg via intraperitoneal injection three times a week for 3 weeks to evaluate its antitumor efficacy. Result: Livmoniplimab treatment Resulted in a 34.3% inhibition of tumor growth. [2] |
| Synonyms | MHG-8, MHG8, ARGX-115, ARGX115, ABBV-151, ABBV151 |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TGFb1 |
| Molecular Weight | ~150 kDa |
| Cas No. | 2412004-88-5 |
| Isotype | Human IgG4(S228P) kappa |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Livmoniplimab | purchase Livmoniplimab | Livmoniplimab cost | order Livmoniplimab | Livmoniplimab in vivo | Livmoniplimab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.